Disease Spotlight: Prostate Cancer

Latest News

Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy
Emerging Medication for mCRPC Gets FDA Fast Track Designation for Adjunctive Use with Radiation Therapy

July 10th 2025

Currently in a phase I trial for solid prostate cancer tumors, the deoxycytidine kinase inhibitor TRE-515 garnered the fast track designation for possible combination use with Pluvicto in treating mCRPC.

CMS Issues Permanent HCPCS Code for the PSMA PET Prep Modality Gozellix
CMS Issues Permanent HCPCS Code for the PSMA PET Prep Modality Gozellix

July 9th 2025

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

June 24th 2025

Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI

June 16th 2025

New PSMA PET Prep Product Now Available in the U.S.
New PSMA PET Prep Product Now Available in the U.S.

June 11th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.